Cartilage damage and/or aging effects can cause constant pain, which limits the patient's quality of life. Although different strategies have been proposed to enhance the limited regenerative capacity of cartilage tissue, the full production of native and functional cartilaginous extracellular matrix (ECM) has not yet been achieved. Poly(γ-glutamic acid) (γ-PGA), a naturally occurring polyamino acid, biodegradable into glutamate residues, has been explored for tissue regeneration. In this work, γ-PGA's ability to support the production of cartilaginous ECM by human bone marrow mesenchymal stem/stromal cells (MSCs) and nasal chondrocytes (NCs) was investigated. MSC and NC pellets were cultured in basal medium (BM), chondrogenic medium (CM), and CM-γ-PGA-supplemented medium (CM+γ-PGA) over a period of 21 days. Pellet size/shape was monitored with time. At 14 and 21 days of culture, the presence of sulfated glycosaminoglycans (sGAGs), type II collagen (Col II), Sox-9, aggrecan, type XI collagen (Col XI), type X collagen (Col X), calcium deposits, and type I collagen (Col I) was analyzed. After excluding γ-PGA's cytotoxicity, earlier cell condensation, higher sGAG content, Col II, Sox-9 (day 14), aggrecan, and Col X (day 14) production was observed in γ-PGA-supplemented MSC cultures, with no signs of mineralization or Col I. These effects were not evident with NCs. However, Sox-9 (at day 14) and Col X (at days 14 and 21) were increased, decreased, or absent, respectively. Overall, γ-PGA improved chondrogenic differentiation of MSCs, increasing ECM production earlier in culture. It is proposed that γ-PGA incorporation in novel biomaterials has a beneficial impact on future approaches for cartilage regeneration.
Get full access to this article
View all access options for this article.
References
1.
BobickB.E., ChenF.H., LeA.M., and TuanR.S.Regulation of the chondrogenic phenotype in culture. Birth Defects Res Part C, 87, 351, 2009.
2.
GoldringM.B.Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis, 4, 269, 2012.
3.
PelttariK., SteckE., and RichterW.The use of mesenchymal stem cells for chondrogenesis. Injury, 39, S58, 2008.
4.
DexheimerV., FrankS., and RichterW.Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells. Stem Cells Dev, 21, 2160, 2012.
5.
OldershawR.A.Cell sources for the regeneration of articular cartilage: the past, the horizon and the future. Int J Exp Pathol, 93, 389, 2012.
6.
SchonB.S., SchrobbackK., van der VenM., StroebelS., HooperG.J., and WoodfieldT.B.F.Validation of a high-throughput microtissue fabrication process for 3D assembly of tissue engineered cartilage constructs. Cell Tissue Res, 347, 629, 2012.
7.
KuoC., LiW.-J., and TuanR.Cartilage and ligament tissue engineering: biomaterials, cellular interactions, and regenerative strategies. In: RatnerB.D., HoffmanA., SchoenF., and LemonsJ., eds. Biomaterials Science: An Introduction to Materials in Medicine. Oxford: Academic Press, 2012, pp. 1214–1236.
8.
BendersK.E.M., van WeerenP.R., BadylakS.F., SarisD.B.F., DhertW.J.A., and MaldaJ.Extracellular matrix scaffolds for cartilage and bone regeneration. Trends Biotechnol, 31, 169, 2013.
9.
FreyriaA.-M., and Mallein-GerinF.Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors. Injury, 43, 259, 2012.
10.
WuL., CaiX., ZhangS., KarperienM., and LinY.Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: perspectives from stem cell biology and molecular medicine. J Cell Physio, 228, 938, 2013.
11.
GiovanniniS., Diaz-RomeroJ., AignerT., HeiniP., Mainil-VarletP., and NesicD.Micromass co-culture of human articular chondrocytes and human bone marrow mesenchymal stem cells to investigate stable neocartilage tissue formation in vitro. Eur Cell Mater, 20, 245, 2010.
SteinertA.F., GhivizzaniS.C., RethwilmA., TuanR.S., EvansC.H., and NoethU.Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther, 9, 213, 2007.
14.
TohW.S., SpectorM., LeeE.H., and CaoT.Biomaterial-mediated delivery of microenvironmental cues for repair and regeneration of articular cartilage. Mol Pharm, 8, 994, 2011.
15.
VinatierC., MrugalaD., JorgensenC., GuicheuxJ., and NoelD.Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol, 27, 307, 2009.
16.
LutolfM.P., and HubbellJ.A.Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol, 23, 47, 2005.
17.
VinatierC., BouffiC., MerceronC., GordeladzeJ., BrondelloJ.-M., JorgensenC., WeissP., GuicheuxJ., and NoëlD.Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther, 4, 318, 2009.
18.
BuescherJ.M., and MargaritisA.Microbial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries. Crit Rev Biotechnol, 27, 1, 2007.
19.
KuoY.-C., and ChangY.-H.Differentiation of induced pluripotent stem cells toward neurons in hydrogel biomaterials. Colloids Surf B Biointerfaces, 102, 405, 2013.
20.
MiyazakiT., KuramotoA., HirakawaA., ShirosakiY., and OhtsukiC.Biomineralization on chemically synthesized collagen containing immobilized poly-gamma-glutamic acid. Dent Mater J, 32, 544, 2013.
21.
ShihI.L., VanY.T., and ShenM.H.Biomedical applications of chemically and microbiologically synthesized poly(glutamic acid) and poly(lysine). Mini Rev Med Chem, 4, 179, 2004.
22.
BrownJ.L., KumbarS.G., and LaurencinC.T.Bone tissue engineering. In: RatnerB.D., HoffmanA., SchoenF., and LemonsJ., eds. Biomaterials Science: An Introduction to Materials in Medicine. Oxford: Academic Press, 2012, pp. 1194–1214.
23.
FujisawaR., and TamuraM.Acidic bone matrix proteins and their roles in calcification. Front Biosci (Landmark Ed), 17, 1891, 2012.
24.
HunterG.K., and GoldbergH.A.Modulation of crystal-formation by bone phosphoproteins - role of glutamic acid-rich sequences in the nucleation of hydroxiapatite by bone sialoprotein. Biochem J, 302, 175, 1994.
25.
SuginoA., MiyazakiT., and OhtsukiC.Apatite-forming ability of polyglutamic acid hydrogels in a body-simulating environment. J Mater Sci Mater Med, 19, 2269, 2008.
26.
KuoY.-C., and ChungC.-Y.TATVHL peptide-grafted alginate/poly(gamma-glutamic acid) scaffolds with inverted colloidal crystal topology for neuronal differentiation of iPS cells. Biomaterials, 33, 8955, 2012.
27.
HinoiE., TakaradaT., UeshimaT., TsuchihashiY., and YonedaY.Glutamate signaling in peripheral tissues. Eur J Biochem, 271, 1, 2004.
28.
SalterD.M., WrightM.O., and Millward-SadlerS.J.NMDA receptor expression and roles in human articular chondrocyte mechanotransduction. Biorheology, 41, 273, 2004.
29.
SkerryT.M., and GeneverP.G.Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci, 22, 174, 2001.
30.
HinoiE., WangL.Y., TakemoriA., and YonedaY.Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage. Biochem Pharmacol, 70, 70, 2005.
31.
PiepoliT., MennuniL., ZerbiS., LanzaM., RovatiL.C., and CaselliG.Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression. Osteoarthritis Cartilage, 17, 1076, 2009.
32.
WangL.Y., HinoiE., TakemoriA., and YonedaY.Release of endogenous glutamate by AMPA receptors expressed in cultured rat costal chondrocytes. Biol Pharm Bull, 28, 990, 2005.
33.
ChangK.-Y., ChengL.-W., HoG.-H., HuangY.-P., and LeeY.-D.Fabrication and characterization of poly(gamma-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering. Acta Biomater, 5, 1937, 2009.
34.
PrescottA.G.Methods for treating joint pain using poly-gamma-glutamic acid. U.S. Patent No. US 2006/0234192 A1, 2006.
35.
BovarnickM.The formation of extracellular d(-)-glutamic acid polypeptide by Bacillus subtilis. J Biol Chem, 145, 415, 1942.
36.
PereiraC.L., AntunesJ.C., GoncalvesR.M., Ferreira-da-SilvaF., and BarbosaM.A.Biosynthesis of highly pure poly-gamma-glutamic acid for biomedical applications. J Mater Sci Mater Med, 23, 1583, 2012.
37.
AshiuchiM., ShimanouchiK., NakamuraH., KameiT., SodaK., ParkC., SungM.H., and MisonoH.Enzymatic synthesis of high-molecular-mass poly-gamma-glutamate and regulation of its stereochemistry. Appl Environ Microbiol, 70, 4249, 2004.
38.
EddeB., RossierJ., LecaerJ.P., DesbruyeresE., GrosF., and DenouletP.Posttranslational glutamylation of alpha-tubulin. Science, 247, 83, 1990.
39.
PrescottA.G., StockL.R. Method for producing medical and commercial grade poly-gamma-glutamic acid of high molecular weight. Crescent Innovations Inc; 2005.
40.
LeeH., ChangM.-J., and KimS.-H.Effects of poly-gamma-glutamic acid on serum and brain concentrations of glutamate and GABA in diet-induced obese rats. Nutr Res Pract, 4, 23, 2010.
41.
ProdhommeE.J.F., TuttA.L., GlennieM.J., and BuggT.D.H.Multivalent conjugates of poly-gamma-D-glutamic acid from Bacillus licheniformis with antibody F(ab') and glycopeptide Ligands. Bioconjugate Chem, 14, 1148, 2003.
42.
AntunesJ.C., PereiraC.L., MolinosM., Ferreira-da-SilvaF., DessiM., GloriaA., AmbrosioL., GonçalvesR.M., and BarbosaM.A.Layer-by-layer self-assembly of chitosan and poly(gamma-glutamic acid) into polyelectrolyte complexes. Biomacromolecules, 12, 4183, 2011.
43.
ParkB.G., KangH.-S., LeeW., KimJ.S., and SonT.-I.Reinforcement of pH-responsive gamma-poly(glutamic acid)/chitosan hydrogel for orally administrable colon-targeted drug delivery. J Appl Polym Sci, 127, 832, 2013.
44.
SerizawaT., GotoH., KishidaA., EndoT., and AkashiM.Improved alternate deposition of biodegradable naturally occurring polymers onto a quartz crystal microbalance. J Polym Sci Part A Polym Chem, 37, 801, 1999.
45.
TsaoC.T., ChangC.H., LinY.Y., WuM.F., WangJ.-L., HanJ.L., and HsiehK.H.Antibacterial activity and biocompatibility of a chitosan-gamma-poly(glutamic acid) polyelectrolyte complex hydrogel. Carbohydr Res, 345, 1774, 2010.
46.
GotoA., and KuniokaM.Biosynthesis and hydrolysis of poly(gamma-glutamic acid) from bacillus-subtilis IFO3335. Biosci Biotechnol Biochem, 56, 1031, 1992.
47.
KubotaH., MatsunobuT., UotaniK., TakebeH., SatohA., TanakaT., and TaniguchiM.Production of poly(gamma-glutamic acid) by bacillus-subtilis F-2-01. Biosci Biotechnol Biochem, 57, 1212, 1993.
48.
U.S. Department of Health and Human Services/Food and Drug Administration/Center for Drug Evaluation and Research/Center for Biologics Evaluation and Research/Center for Veterinary Medicine/Center for Devices and Radiological Health/Office of Regulatory Affairs. Guidance for industry: Pyrogen and endotoxins testing: questions and answers, 2012, pp. 1–10.
49.
GoncalvesR.M., AntunesJ.C., and BarbosaM.A.Mesenhymal stem cell recruitment by stromal derived factor-1 delivery systems based on chitosan/poly(gamma-glutamic acid) polyelectrolyte complexes. Eur Cell Mater, 23, 249, 2012.
50.
GroganS.P., BarberoA., WinkelmannV., RieserF., FitzsimmonsJ.S., O'DriscollS., MartinI., and Mainil-VarletP.Visual histological grading system for the evaluation of in vitro-generated neocartilage. Tissue Eng, 12, 2141, 2006.
51.
IchinoseS., TagamiM., MunetaT., and SekiyaI.Morphological examination during in vitro cartilage formation by human mesenchymal stem cells. Cell Tissue Res, 322, 217, 2005.
52.
Chimal-MonroyJ., and de LeonL.D.Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta 1, beta 2, beta 3 and beta 5 during the formation of precartilage condensations. Int J Dev Biol, 43, 59, 1999.
53.
DenkerA.E., NicollS.B., and TuanR.S.Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth-factor-beta-1. Differentiation, 59, 25, 1995.
54.
LeonardC.M., FuldH.M., FrenzD.A., DownieS.A., MassageJ., and NewmanS.A.Role of transforming growth-factor-beta in chondrogenic pattern-formation in the embryonic limb–stimulation of mesenchymal condensation and fibronectin gene-expression by exogenous TGF-beta and evidence for endogenous TGF-beta-like activity. Dev Biol, 145, 99, 1991.
55.
TuliR., TuliS., NandiS., HuangX.X., MannerP.A., HozackW.J., KeithG., DanielsonK.G., HallD.J., and TuanR.S.Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogenactivated protein kinase and Wnt signaling cross-talk. J Biol Chem, 278, 41227, 2003.
56.
DeLiseA.M., FischerL., and TuanR.S.Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage, 8, 309, 2000.
57.
BiW.M., DengJ.M., ZhangZ.P., BehringerR.R., and de CrombruggheB.Sox9 is required for cartilage formation. Nat Genet, 22, 85, 1999.
58.
Diaz-RomeroJ., NesicD., GroganS.P., HeinP., and Mainil-VarletP.Immunophenotypic changes of human articular chondrocytes during monolayer culture reflect bona fide dedifferentiation rather than amplification of progenitor cells. J Cell Physiol, 214, 75, 2008.
59.
PelttariK., WinterA., SteckE., GoetzkeK., HennigT., OchsB.G., AignerT., and RichterW.Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage, 9, 112, 2001.
60.
SpencerG.J., McGrathC.J., and GeneverP.G.Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng, 20, 145, 2010.
61.
ZuscikM.J., HiltonM.J., ZhangX., ChenD., and O'KeefeR.J.Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest, 118, 429, 2008.
62.
RuggieroF., PetitB., RonziereM.C., FarjanelJ., HartmannD.J., and HerbageD.Composition and organization of the collagen network produced by fetal bovine chondrocytes cultured at high-density. J Histochem Cytochem, 41, 867, 1993.
63.
OxfordJ.T., DeScalaJ., MorrisN., GregoryK., MedeckR., IrwinK., OxfordR., BrownR., MercerL., and CusackS.Interaction between amino propeptides of type XI procollagen alpha 1 chains. J Biol Chem, 279, 10939, 2004.
64.
YingstS., BloxhamK., WarnerL.R., BrownR.J., ColeJ., KenoyerL., KnowltonW.B., and OxfordJ.T.Characterization of collagenous matrix assembly in a chondrocyte model system. J Biol Chem, 90A, 247, 2009.
65.
AignerT., ReichenbergerE., BertlingW., KirschT., StossH., and VondermarkK.Type-X collagen expression in osteoarthritic and rheumatoid articular-cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol, 63, 205, 1993.
66.
GirkontaiteI., FrischholzS., LammiP., WagnerK., SwobodaB., AignerT., and Von der MarkK.Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol, 15, 231, 1996.
67.
BlitterswijkC., ThomsenP., LindahlA., HubbellJ., WilliamsD.F., CanceddaR., de BruijnJ.D., and SohierJ.Tissue Engineering. London: Academic Press, 2008.
68.
CaplanA.Why are MSCs therapeutic? New data: new insight. J Pathol, 217, 318, 2009.
69.
KrugD., KlingerM., HallerR., HargusG., BueningJ., RohwedelJ., and KramerJ.Minor cartilage collagens type IX and XI are expressed during embryonic stem cell-derived in vitro chondrogenesis. Ann Anat, 195, 88, 2013.
70.
UccelliA., MorettaL., and PistoiaV.Mesenchymal stem cells in health and disease. Nat Rev Immunol, 8, 726, 2008.
71.
JohnstoneB., HeringT.M., CaplanA.I., GoldbergV.M., and YooJ.U.In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res, 238, 265, 1998.
72.
PelttariK., WinterA., SteckE., GoetzkeK., HennigT., OchsB.G., AignerT., and RichterW.Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum, 54, 3254, 2006.
73.
ScottiC., TonnarelliB., PapadimitropoulosA., ScherberichA., SchaerenS., SchauerteA., Lopez-RiosJ., ZellerR., BarberoA., and MartinI.Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A, 107, 7251, 2010.
74.
BinetteF., McQuaidD.P., HaudenschildD.R., YaegerP.C., McPhersonJ.M., and TuboR.Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro. J Orthop Res, 16, 207, 1998.
75.
JaehnK., RichardsR.G., ArcherC.W., and StoddartM.J.Pellet culture model for human primary osteoblasts. Eur Cell Mater, 20, 149, 2010.
76.
KoJ.-Y., KimK.-I., ParkS., and ImG.-I.In vitro chondrogenesis and in vivo repair of osteochondral defect with human induced pluripotent stem cells. Biomaterials, 35, 3571, 2014.
77.
MoroniL., and FornasariP.M.Human mesenchymal stem cells: A bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues. J Cell Physiol, 228, 680, 2013.
78.
van GoolS.A., EmonsJ.A.M., LeijtenJ.C.H., DeckerE., StichtC., van HouwelingenJ.C., GoemanJ.J., KleijburgC., ScherjonS.A., GretzN., WitJ.M., RappoldG., PostJ.N., and KarperienM.Fetal mesenchymal stromal cells differentiating towards chondrocytes acquire a gene expression profile resembling human growth plate cartilage. Plos One, 7, e44561, 2012
79.
HellingmanC.A., VerwielE.T.P., SlagtI., KoevoetW., PoublonR.M.L., Nolst-TreniteG.J., Baatenburg de JongR.J., JahrH., and van OschG.J.Differences in cartilage-forming capacity of expanded human chondrocytes from ear and nose and their gene expression profiles. Cell Transplant, 20, 925, 2011.
80.
AsawaY., OgasawaraT., TakahashiT., YamaokaH., NishizawaS., MatsudairaK., MoriY., TakatoT., and HoshiK.Aptitude of auricular and nasoseptal chondrocytes cultured under a monolayer or three-dimensional condition for cartilage tissue engineering. Tissue Eng Part A, 15, 1109, 2009.
81.
ScottiC., OsmokrovicA., WolfF., MiotS., PerettiG.M., BarberoA., and MartinI.Response of human engineered cartilage based on articular or nasal chondrocytes to interleukin-1 beta and low oxygen. Tissue Eng Part A, 18, 362, 2012.
82.
ZhangZ.J., McCafferyJ.M., SpencerR.G.S., and FrancomanoC.A.Hyaline cartilage engineered by chondrocytes in pellet culture: histological, immunohistochemical and ultrastructural analysis in comparison with cartilage explants. J Anat, 205, 229, 2004.
83.
KeeneD.R., OxfordJ.T., and MorrisN.P.Ultrastructural-localization of collagen type-II, type-IX, and type-XI in the growth-plate of human rib and fetal bovine epiphyseal cartilage–type-XI collagen is restricted to thin fibrils. J Histochem Cytochem, 43, 967, 1995.
84.
SwobodaB., HolmdahlR., StossH., and VondermarkK.Cellular heterogeneity in cultured human chondrocytes identified by antibodies specific for alpha-2(XI) collagen chains. J Cell Biol, 109, 1363, 1989.
85.
GroganS.P., MiyakiS., AsaharaH., D'LimaD.D., and LotzM.K.Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther, 11, R85, 2009.
86.
ShenB., WeiA., WhittakerS., WilliamsL.A., TaoH., MaD.D.F., and DiwanA.D.The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J Cell Biochem, 109, 406, 2010.
LefebvreV., HuangW.D., HarleyV.R., GoodfellowP.N., and de CrombruggheB.SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha 1(II) collagen gene. Mol Cell Biol, 17, 2336, 1997.
89.
NgL.J., WheatleyS., MuscatG.E.O., Conway-CampbellJ., BowlesJ., WrightE., BellD.M., TamP.P., CheahK.S., and KoopmanP.SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol, 183, 108, 1997.
90.
BridgewaterL.C., WalkerM.D., MillerG.C., EllisonT.A., HolsingerL.D., PotterJ.L., JacksonT.L., ChenR.K., WinkelV.L., ZhangZ., McKinneyS., and de CrombruggheB.Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res, 31, 1541, 2003.
91.
SekiyaI., TsujiK., KoopmanP., WatanabeH., YamadaY., ShinomiyaK., NifujiA., and NodaM.SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem, 275, 10738, 2000.
92.
AignerT., LoosS., MullerS., SandellL.J., UnniK.K., and KirchnerT.Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas. Am J Pathol, 156, 1327, 2000.
93.
DickhutA., PelttariK., JanickiP., WagnerW., EcksteinV., EgermannM., and RichterW.Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol, 219, 219, 2009.
94.
IchinoseS., YamagataK., SekiyaI., MunetaT., and TagamiM.Detailed examination of cartilage formation and endochondral ossification using human mesenchymal stem cells. Clin Exp Pharmacol Physiol, 32, 561, 2005.
95.
WangL., HinoiE., TakemoriA., NakamichiN., and YonedaY.Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine/glutamate antiporter. J Biol Chem, 281, 24553, 2006.
96.
SpencerG.J., McGrathC.J., and GeneverP.G.Current perspectives on NMDA-type glutamate signalling in bone. Int J Biochem Cell Biol, 39, 1089, 2007.
97.
DanielyanL., SchaeferR., SchulzA., LadewigT., LourhmatiA., BuadzeM., SchmittA.L., VerleysdonkS., KabischD., KoeppenK., SiegelG., ProkschB., KlubaT., EckertA., KöhleC., SchönebergT., NorthoffH., SchwabM., and GleiterC.H.Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin. Cell Death Differ, 16, 1599, 2009.
98.
IemataM., TakaradaT., HinoiE., TaniuraH., and YonedaY.Suppression by glutamate of proliferative activity through glutathione depletion mediated by the Cystine/Glutamate antiporter in mesenchymal C3H10T1/2 stem cells. J Cell Physiol, 213, 721, 2007.
99.
Takarada-IemataM., TakaradaT., NakamuraY., NakataniE., HoriO., and YonedaY.Glutamate preferentially suppresses osteoblastogenesis than adipogenesis through the cystine/glutamate antiporter in mesenchymal stem cells. J Cell Physiol, 226, 652, 2011.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
